Disclosed herein are quinoline compounds of formula (I), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as inhibitors of human immunodeficiency virus (HIV) replication and are therefore useful in the treatment of HIV infection.